Literature DB >> 16638164

Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain.

G Cilla1, A Sarasua, M Montes, N Arostegui, D Vicente, E Pérez-Yarza, E Pérez-Trallero.   

Abstract

This study analysed the role of several risk factors for hospitalization due to community-acquired, respiratory syncytial virus (RSV) infection. The risk factors detected in infants hospitalized for RSV infection in the first 24 months of life were compared with those in the general infant population in our region. There were 361 episodes of hospitalization in 357 infants. Eighty per cent of the infants did not present underlying conditions for severe RSV infection and only 10 (3%) were candidates for palivizumab prophylaxis. In multivariate analysis, birthweight of <2500 g was independently associated with hospitalization for RSV infection and was the most commonly detected medical risk factor. Other risk factors were maternal age at delivery <25 years, birth in the second half of the year, prematurity, suburban residence and congenital heart disease. In conclusion, together with well-known risk factors, we found that low birthweight was an independent factor for severe RSV infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16638164      PMCID: PMC2870431          DOI: 10.1017/S0950268805005571

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  24 in total

1.  Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998.

Authors:  B Müller-Pebody; W J Edmunds; M C Zambon; N J Gay; N S Crowcroft
Journal:  Epidemiol Infect       Date:  2002-08       Impact factor: 2.451

2.  Bronchiolitis-associated hospitalizations among American Indian and Alaska Native children.

Authors:  S A Lowther; D K Shay; R C Holman; M J Clarke; S F Kaufman; L J Anderson
Journal:  Pediatr Infect Dis J       Date:  2000-01       Impact factor: 2.129

3.  [Smoking prevalence in Catalonia (Spain), 1982-1998: a gender perspective].

Authors:  Mireia Jané; Esteve Saltó; Hèlios Pardell; Ricard Tresserras; Rafael Guayta; Josep Lluís Taberner; Lluís Salleras
Journal:  Med Clin (Barc)       Date:  2002-02-02       Impact factor: 1.725

4.  Rehospitalization for respiratory syncytial virus among premature infants.

Authors:  S Joffe; G J Escobar; S B Black; M A Armstrong; T A Lieu
Journal:  Pediatrics       Date:  1999-10       Impact factor: 7.124

5.  Incidence of respiratory syncytial virus-positive hospitalizations in Germany.

Authors:  J A Weigl; W Puppe; H J Schmitt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-07       Impact factor: 3.267

6.  Rates of hospitalization for respiratory syncytial virus infection among children in medicaid.

Authors:  T G Boyce; B G Mellen; E F Mitchel; P F Wright; M R Griffin
Journal:  J Pediatr       Date:  2000-12       Impact factor: 4.406

7.  Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany.

Authors:  Johannes G Liese; Eva Grill; Birgit Fischer; Irmgard Roeckl-Wiedmann; David Carr; Bernd H Belohradsky
Journal:  Eur J Pediatr       Date:  2003-03-01       Impact factor: 3.183

8.  Prevalence of hepatitis A antibody among disadvantaged gypsy children in northern Spain.

Authors:  G Cilla; E Perez-Trallero; J M Marimon; S Erdozain; C Gutierrez
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

9.  Epidemiology of respiratory syncytial virus infection requiring hospitalization in East Denmark.

Authors:  K Kristensen; T Dahm; P S Frederiksen; J Ibsen; E Iyore; A M Jensen; B B Kjaer; K Olofsson; P Pedersen; S Poulsen
Journal:  Pediatr Infect Dis J       Date:  1998-11       Impact factor: 2.129

10.  Impact of respiratory syncytial virus infection as a cause of lower respiratory tract infection in children younger than 3 years of age in Japan.

Authors:  M Kaneko; J Watanabe; M Kuwahara; E Ueno; M Hida; A Kinoshita; T Sone
Journal:  J Infect       Date:  2002-05       Impact factor: 6.072

View more
  28 in total

Review 1.  Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.

Authors:  Cameron Griffiths; Steven J Drews; David J Marchant
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Respiratory viral coinfection among hospitalized patients with H1N1 2009 during the first pandemic wave in Brazil.

Authors:  Clarice Camargo; Sandra Baltazar Guatura; Nancy Bellei
Journal:  Braz J Infect Dis       Date:  2012 Mar-Apr       Impact factor: 1.949

3.  Efficacy of palivizumab prophylaxis on the frequency of RSV-associated lower respiratory tract infections in preterm infants: determination of the ideal target population for prophylaxis.

Authors:  M Cetinkaya; T K Oral; S Karatekin; B Cebeci; A Babayigit; Y Yesil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-04-08       Impact factor: 3.267

4.  Detection of multiple respiratory pathogens during primary respiratory infection: nasal swab versus nasopharyngeal aspirate using real-time polymerase chain reaction.

Authors:  T J Meerhoff; M L Houben; F E J Coenjaerts; J L L Kimpen; R W Hofland; F Schellevis; L J Bont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-01-29       Impact factor: 3.267

Review 5.  Impact of respiratory syncytial virus: the nurse's perspective.

Authors:  Marianne Bracht; Debbie Basevitz; Marilyn Cranis; Rose Paulley
Journal:  Drugs R D       Date:  2011-09-01

6.  Epidemiology of laboratory-confirmed respiratory syncytial virus infection in young children in England, 2010-2014: the importance of birth month.

Authors:  R M Reeves; P Hardelid; R Gilbert; J Ellis; H Zhao; M Donati; R Pebody
Journal:  Epidemiol Infect       Date:  2016-02-26       Impact factor: 4.434

7.  A retrospective population-based cohort study identifying target areas for prevention of acute lower respiratory infections in children.

Authors:  Hannah C Moore; Nicholas de Klerk; Peter Richmond; Deborah Lehmann
Journal:  BMC Public Health       Date:  2010-12-07       Impact factor: 3.295

8.  Comparison of risk factors between preterm and term infants hospitalized for severe respiratory syncytial virus in the Russian Federation.

Authors:  Katherine L Gooch; Gerard F Notario; Gregory Schulz; Konstantin M Gudkov; Katharina Buesch; Hoa Khong; Andrew Campbell
Journal:  Int J Womens Health       Date:  2011-05-06

9.  Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV).

Authors:  Joseph M Geskey; Neal J Thomas; Gretchen L Brummel
Journal:  Biologics       Date:  2007-03

10.  Impact on parents of bronchiolitis hospitalization of full-term, preterm and congenital heart disease infants.

Authors:  Alexandre Lapillonne; Antoine Regnault; Véronique Gournay; Jean-Bernard Gouyon; Hélène Gilet; Daniela Anghelescu; Tatiana Miloradovich; Benoit Arnould; Guy Moriette
Journal:  BMC Pediatr       Date:  2012-10-31       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.